![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Catherine Diefenbach: Polatuzumab Vedotin for Follicular Lymphoma (American Society of Hematology) View |
![]() |
A breakthrough therapy: polatuzumab vedotin plus BR for R/R DLBCL (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
What does the first-line data for polatuzumab vedotin tell us about its role in R/R DLBCL (Lymphoma Hub) View |
![]() |
Phase Ib Polatuzumab Vedotin Trial (OncLive) View |
![]() |
Catherine Diefenbach | ASCO 2018 | Novel therapies for R/R HL beyond transplant (Lymphoma Hub) View |
![]() |
Blood Cancer Awareness: Follicular Lymphoma patent shares her story (FOX 4 Now) View |
![]() |
Frontline Treatment for Follicular Lymphoma (OncLive) View |
![]() |
What are the recent advances in antibody-drug conjugates for lymphoma treatment (Lymphoma Hub) View |
![]() |
Novel ADC for relapsed/refractory lymphoma (ecancer) View |
![]() |
Catherine Diefenbach | ASH 2018 | Novel checkpoint — BV combination shows durable responses in HL (Lymphoma Hub) View |